Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,383 Mln
P/E Ratio
--
P/B Ratio
37.22
Industry P/E
--
Debt to Equity
8.11
ROE
-0.75 %
ROCE
-19.4 %
Div. Yield
0 %
Book Value
2.93
EPS
-3.65
CFO
$-240.75 Mln
EBITDA
$-493.69 Mln
Net Profit
$-576.55 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
iRhythm Technologies (IRTC)
| 18.27 | 1.56 | -4.80 | -4.71 | -5.03 | 1.18 | -- |
|
BSE Sensex
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
iRhythm Technologies (IRTC)
| -15.64 | 14.27 | -20.41 | -50.39 | 248.38 | -2.00 | 23.82 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.69 | 10,562.04 | 12.43 | 12.69 | |
| 72.33 | 10,050.19 | 97.07 | 2.52 | |
| 163.14 | 8,847.72 | -- | -25.23 | |
| 296.91 | 11,609.25 | 277.57 | 3.65 |
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The... company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Address: 699 8th Street, San Francisco, CA, United States, 94103 Read more
President, CEO & Director
Mr. Quentin S. Blackford
President, CEO & Director
Mr. Quentin S. Blackford
Headquarters
San Francisco, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of iRhythm Technologies Inc (IRTC) stood at $ 931 Mln as on 31-Dec-24
The share price of iRhythm Technologies Inc (IRTC) is $106.64 (NASDAQ) as of 29-Apr-2025 16:00 EDT. iRhythm Technologies Inc (IRTC) has given a return of -5.03% in the last 3 years.
iRhythm Technologies Inc (IRTC) has a market capitalisation of $ 3,383 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of iRhythm Technologies Inc (IRTC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the iRhythm Technologies Inc (IRTC) and enter the required number of quantities and click on buy to purchase the shares of iRhythm Technologies Inc (IRTC).
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Address: 699 8th Street, San Francisco, CA, United States, 94103
The CEO & director of Mr. Quentin S. Blackford. is iRhythm Technologies Inc (IRTC), and CFO & Sr. VP is Mr. Quentin S. Blackford.
There is no promoter pledging in iRhythm Technologies Inc (IRTC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| iRhythm Technologies Inc. (IRTC) | Ratios |
|---|---|
|
Return on equity(%)
|
-75.27
|
|
Operating margin(%)
|
-16.88
|
|
Net Margin(%)
|
-19.14
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of iRhythm Technologies Inc (IRTC) was $0 Mln.
